The wonder drug which is widely used for treating the spasticity of skeletal muscles in multiple sclerosis, Baclofen-Lioresal has been designed, developed, manufactured and distributed by an international pharmaceutical corporation named Novartis. The two Swiss based Chemical and Life Sciences giant companies called Ciba-Geigy and Sandoz Company were amalgamated to create the new pharmaceutical giant which is now better known as Novartis. Novartis was thus born precisely on the 7th of March, 1996.
The company is dedicated to build the most promising pipeline in the pharmaceutical industry for treating and helping people across the globe. The term Novartis is said to have been derived from the Latin novae artes which means ‘new skills’ which in turn reflects the commitments of the company of bringing advanced health care products to the patients and physicians across the world.
With its headquarters based at Basel, Switzerland, Novartis is the world leader in offering medicines to protect health, cure ailments and thereby improve well-being. The various product range of the company incorporates generic drugs, consumer health care products and pharmaceuticals. The company in due course developed the ethics committee for assessing research and extricating the mysteries of how cells function and often malfunction related to human stem cells during 2002.
This is not only the significant aspect of the company’s drug discovery efforts but it is indeed enthralling. The company today is literally devoted to cater to the various medical needs through out the world with the help of their multi-sector product range that include: Acromegaly, Asthma, Alzheimer’s Disease, Cancer, Leukemia, Diabetes, Hormone Therapy, Leprosy, Organ Transplant and so on.
|
